Status:
UNKNOWN
Usability Study of CEREBO® - A Novel Non-invasive Intracranial Bleed Detector
Lead Sponsor:
Bioscan Research Pvt. Ltd.
Conditions:
Traumatic Brain Injury
Intracranial Hemorrhages
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Traumatic Brain Injury (TBI) is the leading cause of death and disability across the globe. Time from injury to treatment is the most critical factor that determines the patient's recovery. Mild TBI w...
Detailed Description
This prospective study determines the usability of CEREBO® to detect the intracranial hematoma. The operators will receive a training session before the study and will be evaluated at the end of the s...
Eligibility Criteria
Inclusion
- Operators -
- Medical health professionals \>18 years of age with a valid medical license to practice medicine belonging to one of the following categories and have given a written consent to participate in the study.
- MBBS with Specialisation
- MBBS
- Nursing Staff
- Others
- Subjects -
- Subjects with suspected traumatic brain injury and GCS \> 13
- Of all ages and gender, have understood the study and gave a written informed consent.
Exclusion
- Subjects -
- Subjects with active bleeding or scalp laceration
- Subjects with large extracranial lesions
Key Trial Info
Start Date :
April 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05340114
Start Date
April 25 2022
End Date
May 31 2023
Last Update
April 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.